Sanofi-Aventis Expands R&D Presence In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Sanofi-Aventis recently expanded its R&D presence in China to meet the rapid growth of clinical programs and broaden its activities from drug-target identification to late-stage clinical studies